1. Medtech Insight
  2. >>Policy & Regulation

Raise In Debt Ceiling Means FDA Funding Bill Can Advance

 
• By Sue Darcey

The US House on 25 July signed off on a two-year budget deal for FY 2020 and 2021 raising the federal debt ceiling, and allowing funding for FDA and other federal agencies to go forward.

Debt-ceiling

The US Senate and House this week reached an agreement with the White House to suspend federal government spending limits and raise the debt ceiling, giving a green light for a US Food and Drug Administration appropriations bill to advance.

The House approved its FDA funding bill earlier this summer, giving the agency an overall increase of 6% for FY...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Legislation

More from Policy & Regulation

MDUFA VI Launches With Public Meeting, Call For Comments

 
• By Elizabeth Orr

Preparations for the reauthorization of the Medical Device User Fee Amendments for 2028-2032 are underway, with the US FDA announcing a public meeting for 4 August. After negotiations with industry and other stakeholders, a draft agreement is due to Congress by 15 January 2025.

Permanent FDA Top Lawyer Expected After HHS Counsel Confirmation

 
• By Sue Sutter

Robert Foster, HHS deputy general counsel and chief counsel for food, research and drugs, is temporarily heading the Office of Chief Counsel, but a permanent appointee is expected after Michael Stuart's confirmation as HHS general counsel.

FDA Drops Package Labeling Guidance For Hernia Mesh Manufacturers

 
• By Brian Bossetta

The US FDA recently published a draft guidance document for manufacturers of mesh products that are used during several types of hernia repair procedures.